Gene & Cell Therapies: Q&As

Gene & Cell therapies bring high hopes for millions of patients in Europe, but they do also raise some questions.

We have assembled some of the frequently asked questions. To help you getting a better idea.

Upcoming Meetings

Market Access / Pricing & Reimbursement Meeting, Brussels, 04 June

France BioTech HealthTech Investor Day, Paris, 24 June

Members Meeting, Brussels, 25 June


EUCOPE Membership

The content of the member area is exclusively available for members of EUCOPE.

To learn more about the advantages of the EUCOPE membership please contact us.

Contact us or Login

EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs

EUCOPE is Europe’s trade body for small to medium-sized innovative companies working in the field of pharmaceuticals, biotechnologies and medical technologies.

Based in Brussels, Belgium, EUCOPE gives voice to more than 120 research-oriented innovative companies and associations active in research, development of pharmaceuticals, biotechnologies and medical devices. Many of our members are developing therapeutic solutions for persons living with a rare disease, who had little to no treatment available just a few years ago.

As an industry stakeholder recognised by the European Institutions (EMA, European Commission, European Parliament and Council) and by national authorities, EUCOPE is following important EU and national legislative dossiers in market access, rare diseases, pharmacovigilance, and medical devices, with a speficic focus on the incentives framework.

Together with our members, we work to ensure an effective framework is in place to allow small to medium-sized pharmaceutical companies to continue to provide innovative solutions for patients in Europe.